MedTrace Logo

Oral Tolerability Of Two Nicotine Dosage Forms

NCT00682461 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-03-01

Study results available
· View outcomes & findings →

Summary

This study is to evaluate the oral tolerability of a nicotine prototype

Conditions

  • Healthy Volunteer Smokers

Interventions

DRUG

Nicotine

Marketed nicotine replacement therapy formulation

DRUG

Nicotine

Nicotine prototype

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00682461 on ClinicalTrials.gov